Skip to content

Clinical trials

Completed Phase 1 Carcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma Phase: Phase 1 Status: Completed Clear all

82 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20032
20042
20056
20064
20074
20088
20096
20108
20115
20124
20133
20142
20156
20164
20172
20193
20203
20214
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed82

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Akamis Bio5
Pfizer5
National Cancer Institute (NCI)4
Amgen3
AstraZeneca3
Celgene2
H. Lee Moffitt Cancer Center and Research Institute2
Merck Sharp & Dohme LLC2
Providence Health & Services2
TaiRx, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma82
Neoplasms30
Neoplasm Metastasis18
Carcinoma, Non-Small-Cell Lung10
Lymphoma8
Melanoma6
Sarcoma6
Adenocarcinoma5
Colorectal Neoplasms5
Lung Neoplasms5

Trials

Showing 1 to 25 of 82. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.